To determine if levels of serum total homocysteine are elevated in patients with either cobalamin or folate deficiency, we utilized a new capillary gas chromatographic-mass spectrometric technique to measure total homocysteine in the serum of 78 patients with clinically confirmed cobalamin deficiency and 19 patients with clinically confirmed folate deficiency. Values ranged from 11 to 476 itmol/liter in the cobalamin-deficient patients and 77 of the 78 patients had values above the normal range of 7-22 ;tmol/liter as determined for 50 normal blood donors. In the cobalamin-deficient patients, serum total homocysteine was positively correlated with serum folate, mean corpuscular volume, serum lactate dehydrogenase, serum methylmalonic acid, and the degree of neurologic involvement, and inversely correlated with platelets and hematocrit. In the folate-deficient patients, values for serum total homocysteine ranged from 17 to 185 gmol/liter and 18 of the 19 patients had values above the normal range. Some patients with pernicious anemia who were intermittently treated with cyanocobalamin were found to have elevated serum levels of total homocysteine while they were free of hematologic and neurologic abnormalities. The measurement of serum total homocysteine will help define the incidence of cobalamin deficiency and folate deficiency in various patient populations.
Introduction
At present the diagnosis of cobalamin (Cbl, I vitamin B12) deficiency and folate deficiency are almost entirely dependent on the demonstration of low serum levels of the vitamins in patients with supportive clinical and laboratory findings. The limitations in using only the serum Cbl level to detect Cbl deficiency have been widely recognized (1) (2) (3) (4) . For example, the significance of the high incidence of low serum Cbl values in elderly subjects without hematologic abnormalities (5, 6), puscular volume. and in patients who have various neuropsychiatric abnormalities (7, 8) , is not known. Other tests (9) , such as the deoxyuridine suppression test, have not been widely used to assess patients for Cbl deficiency.
The diagnosis of folate deficiency can also be problematic for several reasons. For instance, after acute dietary deprivation, serum folate levels may be decreased, although tissue folate levels are adequate (10) . In the setting of chronic alcoholism, the laboratory features of megaloblastic anemia due to folate deficiency may be confused by concurrent illness. Serum and red blood cell folate may be normal in patients with alcoholism and megaloblastic anemia (1 1). Finally, because many of the clinical and laboratory features of Cbl and folate deficiency are similar, it is often difficult to distinguish between them (12) , and the administration of folic acid alone to a patient with Cbl deficiency is dangerous (13). Therefore, as in Cbl deficiency syndromes, additional diagnostic tests for folate deficiency would be useful.
In both Cbl and folate deficiency, it is likely that there is reduced activity of the Cbl-dependent enzyme, methionine synthetase (tetrahydropteroylglutamate methyltransferase), which simultaneously methylates homocysteine to methionine while demethylating N5-methyltetrahydrofolate to tetrahydrofolate, as shown in Fig. 1 . The reduced folates formed from this reaction are necessary for thymidine synthesis and ultimately DNA synthesis, and the methionine formed participates in the methylation of many compounds (14) . If methionine synthetase activity is decreased by a deficiency ofCbl or folate, serum homocysteine levels might increase and methionine levels might decrease, although regulation of other enzymes in the pathway shown in Fig. 1 might maintain levels of one or both of these amino acids within normal limits. A few (15-20) but not all (21-24) children with severe Cbl deficiency have been reported to have increased levels of homocystine in their urine and plasma, along with decreased levels ofplasma methionine. An early study (25) reported that plasma methionine levels were low in adults with Cbl deficiency. In addition, excretion of large amounts of homocystine in the urine has been reported in patients with various inherited defects affecting the activity of methionine synthetase such as the inability to form methylcobalamin (Cbl C and Cbl D mutants) (26, 27), and an inability to form N5-methyltetrahydrofolate due to 5, 10-methylenetetrahydrofolate reductase deficiency (28, 29) . However, homocystinuria was not present in patients with transcobalamin II deficiency (30) , a patient with a lysosomal block in Cbl transport (31), or in a patient with congenital folate malabsorption (32) , all ofwhom had hematologic abnormalities that would be associated with a decrease in methionine synthetase activity.
We have developed a new capillary gas chromatographic- 10 and 25% at 4 and 24 h, respectively. Values for serum total cysteine were unchanged over the 24-h incubation period. Values for urine total homocysteine, total cysteine, and total methionine were unchanged when urine samples were incubated at room temperature for 0-24 h. Serum samples and the internal standards of homocysteine, methionine, and cysteine were stable for > 1 yr, based on their gas chromatographic-mass spectrometric behavior, when stored at -20°C in between numerous freezings and thawings over this time period.
Subjects and patients. Serum samples from 50 normal blood donors, 25 males and 25 females, ranging in age from 18 to 65 yr were obtained as described previously (35) . Patient samples were selected by Dr. Lindenbaum from an extensive serum collection that has been assembled over the past 15 yr. Both the normal and the patient samples were allowed to clot for -1-4 h at room temperature before the serum was removed and stored at -20°C. Thus, postcollection increases for total homocysteine and methionine should have been modest and similar in both the normal and patient groups (see above). The Schilling test that corrected with exogenous intrinsic factor and/or the presence ofanti-intrinsic factor-blocking antibodies in the serum. The diagnosis of folate deficiency was based on low serum folate values, normal or elevated serum Cbl values, megaloblastic bone marrow morphology, appropriate hematologic abnormalities, and responses to folic acid therapy. In 17 ofthe patients there was a history ofalcoholism and poor diet; one had history of poor diet alone, and one had tropical sprue. The samples in the Cbl-deficient infrequently treated group were from patients with pernicious anemia who were previously diagnosed as Cbl deficient as described above, but who received only intermittent treatment with parenteral Cbl at intervals of 6-9 mo due to poor compliance or as part of studies of Cbl requirements to be reported elsewhere. They had low, borderline, or normal levels for serum Cbl, lacked hematologic and neurologic abnormalities, and were asymptomatic at the time the samples were collected. Serum Cbl levels were assayed using the Lactobacillus leichmannii method or a number of radiodilution assays utilizing purified intrinsic factor or gastric juice with > 95% ofCbl binding activity due to intrinsic factor. These assays were performed in Dr. Lindenbaum's laboratory where it has been found that very similar patient values and normal ranges are obtained with all of the various Cbl assays. Serum folate was assayed with the Lactobacillus casei method or by milk binder radiodilution assay. Most of the patients' samples were coded in a manner such that the categories to which they belonged and the number of patients in each category were not known by the personnel involved in the performance of the total homocysteine, methionine, and total cysteine assays, until after the results were reported to Dr. Lindenbaum. A large number of Dr. Lindenbaum's samples from patients without Cbl or folate deficiency have been assayed and found to have normal values for these amino acids, thus ruling out the possibility that elevated values might arise due to storage in the freezers used in Dr. Lindenbaum's laboratory.
Statistical methods. A number of factors were examined individually for possible relationships with serum total homocysteine, methionine, and total cysteine. For factors that were discreet, such as sex, race, and diagnosis, the Wilcoxon two-sample test was used to determine the significance of the relation. For assessing possible relationships with neurologic severity, groups 0, 1, and 2 (as defined in Table I ) were combined and compared with combined groups 3 and 4. Factors that were continuous, such as age or mean corpuscular volume (MCV), were examined using Spearman correlation coefficients.
Results
The values obtained for serum total homocysteine, methionine, and serum total cysteine for the normal subjects and patients in the various categories are shown in Fig. 2 Figure 2 . Levels of serum total homocysteine (bottom), serum methionine (middle), and serum total cysteine (top) in patients with clinically confirmed Cbl deficiency, folate deficiency, and Cbl-deficient infrequently treated patients who had no hematologic or neurologic abnormalities, using capillary gas chromatography-mass spectrometry. The normal range for total homocysteine is (7-22 umol/liter), for methionine Amol/liter), and for cysteine (173-378 ,umol/ liter). These ranges were calculated as the mean±2 SD after log transformation to correct for skewness towards higher values.
To determine ifthe elevations ofserum total homocysteine were due to Cbl or folate deficiency and not due to illness in general, we studied 25 consecutive patients (13 hospitalized, 12 outpatients; age, 25-86 yr) who had sera submitted for serum Cbl and serum folate assays and in whom the Cbl values were > 500 pg/ml (normal, 200-1,000 pg/ml) and the folate values were > 5 ng/ml (normal, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 89 ,umol/liter) (P < 0.01). Serum total homocysteine was not significantly correlated with serum Cbl (r = -0.20, P < 0.08). There was no significant correlation between serum total homocysteine and any of the following: serum methionine, serum total cysteine, sex, race, etiology, presence of anti-intrinsic factor antibody, and presence of glossitis. Serum methionine was not significantly correlated with any of the parameters mentioned above and significant differences were not observed between any ofthe various subgroups.
The hematologic data presented in Table I on the 77 Cbldeficient patients with elevated levels of total homocysteine, demonstrates wide variations in their degree of anemia, macrocytosis, and other abnormalities. For instance, only 32 (42%) had a severe anemia (Hct < 25%), while 27 (35%) had only a moderate degree of anemia (Hct, 25-34% for females, 25-39% for males), and 18 (23%) were not anemic at all. Only 45 (58%) of the patients had a marked elevation in MCV (> 1 10 fl), while 23 (30%) had only a moderate elevation of MCV (101-1 10 fl), and 9 (12%) had a normal MCV. There was a wide range of serum Cbl levels in these patients also; only 47 (61%) had markedly decreased levels to < 100 pg/ml, while the other 30 (39%) had levels between 100 and 200 pg/ml.
The clinical data on the 19 patients with folate deficiency along with their serum total homocysteine, methionine, total cysteine, and methylmalonic acid values are also shown in Table I . Because of the small number of patients tested, correlations between their clinical and laboratory abnormalities were not evaluated.
We have previously reported that serum methylmalonic acid is increased in 95% ofpatients with Cbl deficiency (33). As shown in Table I As we have reported previously (33), most folate-deficient patients have normal levels of serum methylmalonic acid, although some have mild elevations. In the current study, as shown in Table I , 13 of the 19 folate-deficient patients had normal values for serum methylmalonic acid, and the other 6 had mild elevations (median for the 6 patients, 132 ng/ml, range, 79 to 195 ng/ml). Fig. 3 shows the serum and urine homocysteine levels both before and after treatment in a patient with classic pernicious anemia and in another patient with alcoholism and nutritional folate deficiency. The Cbl-deficient patient had markedly elevated levels of total homocysteine both in serum and urine, which fell into the normal range within 3 d of treatment with parenteral cyano-Cbl (CN-Cbl). This same patient has been previously shown (33) to have a similar rapid fall in serum and urine methylmalonic acid in response to this course ofCN-Cbl treatment. The patient with folate deficiency had an elevated serum total homocysteine which over several days decreased to the upper border ofthe normal range after several doses oforal folic acid. The urine total homocysteine which was at the upper border of the normal range also fell markedly after treatment. This data suggests that serum and urine homocysteine levels correlate with each other in patients with Cbl or folate deficiency and could be used to monitor the response of treatment, although more patients would need to be evaluated before this could be concluded with certainty. Initial serum and urine methionine levels were normal in both patients and did not change significantly after CN-Cbl or folate treatment (data not shown).
Discussion
Our studies demonstrate that serum total homocysteine levels are likely to be clinically useful, since they were above the normal range in 77 of 78 Cbl-deficient patients and 18 of 19 folate-deficient patients. The serum total homocysteine appears to be similar in sensitivity to the serum methylmalonic acid in the Cbl-deficient patients, since the latter was elevated in 74 of the same 78 Cbl-deficient patients. Using the serum total homocysteine level in combination with the serum methylmalonic acid level will often be helpful in distinguishing patients with Cbl deficiency from those with folate deficiency, since most patients with folate deficiency have normal levels of serum methylmalonic acid and the rest have only mild elevations.
Additional clinical studies using measurements of serum total homocysteine and serum methylmalonic acid in addition to measurements of serum Cbl and serum folate should make it possible to further define the clinical spectra of Cbl and folate deficiency, and to define the proper diagnostic approach That levels of serum total homocysteine are almost always elevated in deficiencies of Cbl and folate, whereas levels of serum methionine are almost never decreased in these conditions, indicates that the pathways shown in Fig. 1 are regulated to a considerable degree. The maintenance of methionine levels within a relatively narrow range appears reasonable, since methionine is an essential amino acid that plays an important role in protein synthesis, in various methylations, and in a large number of other metabolic reactions. The enzymatic reaction or reactions that represent the site or sites of regulation in Cbl deficiency and in folate deficiency are not known. Cystathione ,B-synthase (see Fig. 1 ) could play a role, since regulation of this enzyme is important in the maintenance of methionine homeostasis during changes in dietary methionine (38-40).
The fact that methionine levels are maintained in Cbl and folate deficiency at the expense of elevated levels of total homocysteine might be harmful, since elevations in homocysteine due to homozygosity or heterozygosity for cystathionine synthetase deficiency have been associated with an increase in vascular disease and thrombosis (41-43). That these problems have not been reported as being present in increased incidence in Cbl deficiency or in folate deficiency may be due to the shorter duration of Cbl and folate deficiencies or to possible differences in other regulatory factors that may exist in these conditions.
Our finding that serum total homocysteine is negatively correlated with platelet count and Hct and positively correlated with MCV and LDH in the Cbl-deficient patients supports the concept that a block in methionine synthetase activity occurs in Cbl deficiency and that this block is responsible for the megaloblastic anemia and other hematologic abnormalities that are seen in these patients (12) , and which are indistinguishable from those seen in patients with folate deficiency. We have previously reported (33) and have found in this study that serum methylmalonic acid is not significantly correlated with Hct, MCV, or LDH in Cbl-deficient patients. This supports the concept that the second Cbl-dependent enzyme, L-methylmalonyl-CoA mutase, does not play a role in the megaloblastic anemia and other hematologic abnormalities seen in Cbl deficiency.
The cause of the neuropsychiatric abnormalities that are seen in Cbl deficiency but not in folate deficiency has long been of interest. Some investigators have favored a defect in L-methylmalonyl-CoA mutase as the cause and have suggested that the neuropsychiatric abnormalities are due to a buildup in propionyl-CoA and a resultant increase in odd number carbon fatty acids in peripheral nerves and the central nervous system (44) (45) (46) neuropsychiatric abnormalities in patients with Cbl deficiency. Our finding that serum methionine is not decreased in patients with Cbl deficiency would appear to argue against a mechanism involving a lack of methionine as the cause of the neuropsychiatric abnormalities, but it should be emphasized that levels of methionine in serum may not reflect levels of methionine in peripheral nerves and the central nervous system. Measurements of methylmalonic acid, total homocysteine, and methionine in cerebral spinal fluid and various tissues would be of interest in this regard.
